498 related articles for article (PubMed ID: 28544521)
21. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
Xu L; Anchordoquy T
J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
[TBL] [Abstract][Full Text] [Related]
22. Oral delivery of siRNA and antisense oligonucleotides.
Akhtar S
J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907
[TBL] [Abstract][Full Text] [Related]
23. Towards safe nanoparticle technologies for nucleic acid therapeutics.
Miller AD
Tumori; 2008; 94(2):234-45. PubMed ID: 18564612
[TBL] [Abstract][Full Text] [Related]
24. Oral peptide delivery: Translational challenges due to physiological effects.
Tyagi P; Pechenov S; Anand Subramony J
J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
[TBL] [Abstract][Full Text] [Related]
25. Non-viral nucleic acid delivery: key challenges and future directions.
Elsabahy M; Nazarali A; Foldvari M
Curr Drug Deliv; 2011 May; 8(3):235-44. PubMed ID: 21291381
[TBL] [Abstract][Full Text] [Related]
26. Development of targeted delivery systems for nucleic acid drugs.
Mahato RI; Takakura Y; Hashida M
J Drug Target; 1997; 4(6):337-57. PubMed ID: 9239575
[TBL] [Abstract][Full Text] [Related]
27. Oral delivery of nucleic acid-based therapeutics.
Hardee GE
Ther Deliv; 2012 Feb; 3(2):143-5. PubMed ID: 22834192
[No Abstract] [Full Text] [Related]
28. Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies.
Padmakumar S; D'Souza A; Parayath NN; Bleier BS; Amiji MM
J Control Release; 2022 Dec; 352():121-145. PubMed ID: 36252748
[TBL] [Abstract][Full Text] [Related]
29. Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.
Ball RL; Bajaj P; Whitehead KA
Sci Rep; 2018 Feb; 8(1):2178. PubMed ID: 29391566
[TBL] [Abstract][Full Text] [Related]
30. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
Iyer AK; Duan Z; Amiji MM
Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
[TBL] [Abstract][Full Text] [Related]
31. Enhancing and targeting nucleic acid delivery by magnetic force.
Plank C; Anton M; Rudolph C; Rosenecker J; Krötz F
Expert Opin Biol Ther; 2003 Aug; 3(5):745-58. PubMed ID: 12880375
[TBL] [Abstract][Full Text] [Related]
32. Nanoscale platforms for messenger RNA delivery.
Li B; Zhang X; Dong Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1530. PubMed ID: 29726120
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and Biodistribution Analysis of Small Interference RNA for Silencing Tissue Transglutaminase-2 in Celiac Disease After Oral Administration in Mice Using Gelatin-Based Multicompartmental Delivery Systems.
Attarwala HZ; Suri K; Amiji MM
Bioelectricity; 2020 Jun; 2(2):167-174. PubMed ID: 34471844
[No Abstract] [Full Text] [Related]
34. Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier.
Nafee N; Gouda N
Curr Gene Ther; 2017; 17(2):154-169. PubMed ID: 28494740
[TBL] [Abstract][Full Text] [Related]
35. miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?
Hossian AKMN; Mackenzie GG; Mattheolabakis G
Nanomedicine (Lond); 2019 Nov; 14(21):2873-2889. PubMed ID: 31735124
[TBL] [Abstract][Full Text] [Related]
36. Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
Dobrovolskaia MA; McNeil SE
Expert Opin Drug Deliv; 2015 Jul; 12(7):1163-75. PubMed ID: 25994601
[TBL] [Abstract][Full Text] [Related]
37. Vectorization of Nucleic Acids for Therapeutic Approach: Tutorial Review.
Geinguenaud F; Guenin E; Lalatonne Y; Motte L
ACS Chem Biol; 2016 May; 11(5):1180-91. PubMed ID: 26950048
[TBL] [Abstract][Full Text] [Related]
38. Application of vinyl polymer-based materials as nucleic acids carriers in cancer therapy.
Pereira PA; Serra MES; Serra AC; Coelho JFJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1820. PubMed ID: 35637638
[TBL] [Abstract][Full Text] [Related]
39. Engineering strategies to enhance nanoparticle-mediated oral delivery.
Yamanaka YJ; Leong KW
J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
[TBL] [Abstract][Full Text] [Related]
40. Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route.
Chen F; Liu Q; Xiong Y; Xu L
Front Pharmacol; 2022; 13():984981. PubMed ID: 36105233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
